Ecology and Evolution of Infectious Diseases Initiative (EEID)

Status: Accepting applications

Apply through NSF program solicitation- https://www.nsf.gov/pubs/2018/nsf18581/nsf18581.htm#toc 

Program Overview

This joint National Institutes of Health (NIH) - National Science Foundation (NSF) initiative supports efforts to understand the underlying ecological and biological mechanisms that govern relationships between human-induced environmental changes and the emergence and transmission of infectious diseases. The highly interdisciplinary research projects funded under this program apply both ecological and biomedical methods, and study how environmental events such as habitat alteration, biological invasion, climate change, and pollution alter the risks of emergence and transmission of viral, parasitic, and bacterial diseases in humans and other animals. Projects are encouraged to consider how integrated environmental and biomedical approaches to infectious diseases may enhance our ability to predict and control them.

Eligibility: 

Who May Submit Proposals:

The categories of proposers eligible to submit proposals to the National Science Foundation are identified in the NSF Proposal & Award Policies & Procedures Guide(PAPPG), Chapter I.E.

Who May Serve as PI:

There are no restrictions or limits.

Limit on Number of Proposals per Organization:

There are no restrictions or limits.

Limit on Number of Proposals per PI or Co-PI: 2

In a given year, an individual may participate as a PI, co-PI, or sub-award lead on no more than two proposals submitted in response to this solicitation. This limit does not include RCN proposals. In addition, an individual from Israel may participate in no more than oneUS-BSF proposal and an individual from China may participate in no more than one US-China proposal. Proposals in excess of the limit for any person will be returned without review in the reverse order received. Participating in a proposal as other senior personnel does not count in this limit. Changes in investigator roles post-submission to meet the eligibility limits will not be allowed. It is the responsibility of the submitters to confirm that the entire team is within the eligibility guidelines.

Deadlines

• Upcoming application deadline: November 21, 2018
• Estimated future deadlines: third Wednesday in November, annually

Recent Awards

• View a full list of NIH EEID Awards
• View a full list of NSF EEID Awards

More information

https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5269

Inquiries

Programmatic Issues

Dr. Christine Jessup
Program Officer
Fogarty International Center
National Institutes of Health
Building 31, B2C39
31 Center Drive MSC 2220
Bethesda, MD 20892-2220
Phone: (301) 496-1653
Fax: (301) 402-0779
Email: Christine.Jessup@nih.gov

Grants Management

Mollie Shea
Grants Management Specialist
Fogarty International Center
National Institutes of Health
Building 31, Room B2C29
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220
Telephone: 301-496-9750
Fax: 301-594-1211
Email: Mollie.Shea@nih.gov

Fogarty Emerging Global Leader Award

Program Overview

The Fogarty Emerging Global Leader Award aims to provide research support and protected time to a research scientist from a LMIC who holds an academic junior faculty position or research scientist appointment at an LMIC academic or research institution. Low-income, lower-middle-income and upper-middle-income countries are included.

Applications are invited from LMIC research scientists from any health-related discipline who propose both critically needed career development activities and a research project that is highly relevant to the health priorities of their country.

Status: Accepting applications

Eligibility

• Some current and former NIH PDs/PIs are not eligible, as specified in the May 31, 2017 notice of change in eligibility (NOT-TW-17-004).
• Updated Notice of change in eligibility (NOT-TW-18-002), released November 8, 2017
• Only low- or middle-income country (LMIC) institutions are eligible.
• Income categories are defined by The World Bank Country and Lending Groups .
• Country eligibility for Fogarty International Training Grants applies.
• Candidates must be LMIC citizens.
• Candidates must hold an academic junior faculty position or research scientist appointment at the LMIC applicant institution and must have been in this position for at least one year at the time the application is submitted.
• Candidates are required to have both U.S. and LMIC primary mentors.
• Research should take place primarily in the LMIC.
• Individuals who have already received independent research funding are not eligible.
• Applicants should demonstrate that they are committed to an independent research career and justify the need for three to five years of mentored research experience in order to become an independent research scientist.
• View full eligibility details in the program announcement and refer to FAQs.

Deadlines

• Letter of Intent due dates: 30 days before the application due date​
• Upcoming application due date: November 7, 2018

Recent Awards

View a list of Emerging Global Leader awards by institution.

Frequently Asked Questions

​Access answers to frequently asked questions (FAQs) about the Fogarty Emerging Global Leader Award

.
More information- https://www.fic.nih.gov/Programs/Pages/emerging-global-leader.aspx?utm_source=funding-news&utm_medium=email&utm_campaign=funding-news

Planning for Non-Communicable Diseases and Disorders Research Training Programs in Low and Middle Income Countries (NIH)

Funding Opportunity Announcement (FOA) Number: PAR-17-097

D71 International Research Training Planning Grant

Funding Opportunity Purpose

This  Funding Opportunity Announcement (FOA) for research training program planning invites submissions from low- and middle-income country (LMIC) institution(s) with existing research and research training capacity in chronic, non-communicable diseases and disorders (NCDs). These institutions must propose to assess needs and develop a plan for a research training program within the LMIC(s) that will further strengthen the capacity of LMIC individuals, institution(s) and country(ies) to identify NCD priorities and conduct NCD research across the lifespan. The application from the LMIC institution(s) may include collaboration with United States (U.S) institutions and other LMIC institutions as justified and appropriate.    

Research Objectives

• To assess the existing research and research training capacity at the applicant LMIC institution in the proposed scientific area(s) that are directly relevant to the LMIC health priorities in order to show feasibility to develop a new or continued research training program directed from and at the LMIC institution;
• To develop a detailed vision and strategies for implementing an innovative research training program at and led by the LMIC institution for multiple scientists and health research professionals;
• To plan to strengthen both the trainees' capacity to conduct, and the applicant LMIC institution's capacity to support and promote, independent, sustainable research;
• To identify the research training, faculty development, scientific environment and administrative resources still needed to undertake such a research training program by the LMIC institution after building on prior initiatives such as collaborations under an FIC D43.
• To define a pool of the best-qualified potential LMIC trainees that could be recruited and the selection process for future research training;
• To develop defined collaborations and roles of all individual and institutional partners for an effective organizational structure that will support the envisioned D43 research training program; and
• To lay the foundation for sustainable, competitive NCD D43 research training program in and led by the LMIC(s).

Eligibility
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Award Budget
Application budgets are limited $46,000 (total direct costs).

Award Project Period
The maximum project period is 1 year.

Key Dates
Open Date (Earliest Submission Date): February 14, 2017  

Letter of Intent Due Date(s): 30 days prior to the application due date  

*Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review: June 2019  
Advisory Council Review: August 2019
Earliest Start Date: February 2020
Expiration Date: March 15, 2019

Deadline
Application Due Date(s):
March 14, 2019 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Full details: https://grants.nih.gov/grants/guide/pa-files/PAR-17-097.html

Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases (NIH)

Funding Opportunity Announcement (FOA) Number: RFA-AI-18-025

R21 Exploratory/Developmental Research Grant

Funding Opportunity Purpose
The purpose of this Funding Opportunity Announcement (FOA) is to support Exploratory/Developmental Grant (R21) applications to uncover functional roles of non-coding RNAs (ncRNAs) in viral infectious diseases. Importantly, studies should focus on functional characterization and mechanistic studies of previously identified ncRNAs. 

Research Objectives and Scope
The objective of this FOA is to stimulate hypothesis-driven research to facilitate transition of the ncRNA field from discovery toward a deeper mechanistic understanding of the function and regulation of ncRNAs, which will serve as a foundation for future translational research efforts.

This FOA is intended to support research on both host and viral ncRNAs including, but not limited to, those involved in

Viral transcription and replication
Regulation of host response to infection
Pathogenesis
Disease progression and severity
Response to vaccination or treatment

Eligibility
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Award Budget
The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Award Project Period
The total project period may not exceed 2 years. 

Key Dates
Open Date (Earliest Submission Date): October 15, 2018

Letter of Intent Due Date(s): October 15, 2018

*Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review: March 2019
Advisory Council Review: May 2019
Earliest Start Date: July 2019
Expiration Date: November 16, 2018

Deadline
Application Due Date(s):
November 15, 2018 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Full details: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-18-025.html

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (NIH)

Funding Opportunity Announcement (FOA) Number: PAR-18-242

R21 Exploratory/Developmental Research Grant

Funding Opportunity Purpose

The purpose of this Funding Opportunity Announcement (FOA) is to encourage exploratory/developmental research applications that propose to conduct research to develop or adapt innovative mobile health (mHealth) technology specifically suited for low and middle income countries (LMICs) and determine the health-related outcomes associated with implementation of the technology. Of highest interest are innovative, well-designed multidisciplinary projects that aim to generate generalizable knowledge for the field.

The overall goal of the FOA is to contribute to the evidence base for the use of mobile technology to improve clinical outcomes and public health while building research capacity in LMICs and establishing research networks in this area. Applicants are required to propose partnerships between at least one U.S. institution and one LMIC institution and the proposed research plan should strengthen the mHealth research capabilities at the LMIC institution.  

Research Objectives and Scope

This FOA encourages research projects that study the development/adaptation and effectiveness of mHealth tools and/or interventions for the prevention, diagnosis, management, and treatment of specific health conditions or for disease agnostic/cross-cutting applications. Applicants are encouraged to propose research projects that have the potential to provide an understanding of principles underlying effective mHealth interventions or tools that are generalizable to the field.

Applications should have a strong emphasis on health-related outcomes upon application of the tool or intervention and should include rigorous study designs. Pilot studies that are necessary for more comprehensive future research projects may be proposed. Formative research that is necessary for technology development or project implementation (e.g. research on cultural acceptability) may be one aspect of the proposed research.

This initiative aims to support projects that adapt or develop technologies that are appropriate for LMIC settings. A plethora of mHealth applications and devices have been developed in high-income countries, however, these technologies are not necessarily suitable for the needs of individuals in LMICs. Research that focuses on the problems and constraints in LMIC environments should produce more effective interventions and tools and may result in more sustainable mHealth use, especially if there is involvement from LMIC stakeholders, such as businesses, hospitals, or governments.

Eligibility

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Award Budget

Applicants may request up to $125,000 direct costs per year.  

Award Project Period

The total project period may not exceed 2 years.  

Key Dates

Open Date (Earliest Submission Date): August 1, 2018

Letter of Intent Due Date(s): 30 days prior to the application due date

*Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review: February/March 2019

Advisory Council Review: May 2019

Earliest Start Date: July 2019

Expiration Date: September 1, 2018

Deadline

Application Due Date(s): 
August 31, 2018 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Full details: https://grants.nih.gov/grants/guide/pa-files/PAR-18-242.html

Notable Award:
Duke University
Novel mHealth Technologies to Enhance PrEP Adherence among Thai YMSM: Collaborative Adaption and Evaluation

Novel Approaches for Relating Genetic Variation to Function and Disease (NIH)

Funding Opportunity Announcement (FOA) Number: PA-18-867

R21 Exploratory/Developmental Research Grant

Funding Opportunity Purpose

Genome-wide association studies and other disease studies have identified many variants that are statistically associated with disease risk, disease protection, or other traits.  However, such studies do not generally show which specific variants in genomic elements cause these effects, or how they result in differences in function.  Similarly, genomic sequencing studies in clinical settings have identified many variants in healthy and diseased individuals.  However, the pathogenicity of such variants is often unknown, leading to their classification as variants of uncertain significance (VUS), which makes clinical implementation difficult.  This Program Announcement and the companion R21 Program Announcement aim to support the development of novel and generalizable approaches to study how genetic variants lead to differences in function and to study how such functional differences affect human health and disease processes or how this knowledge can be used clinically.

Research Objectives and Scope

This FOA aims to support research that develops novel, transformative, and generalizable genomic approaches to study the functional and disease effects of genomic variation, specifically how differences in sequence lead to differences in genome function, and to better understand how functional differences lead to disease risk or traits, or how to this knowledge can be used clinically.  These new approaches could fall into a range of activities, from exploring novel concepts, developing new methods, or developing new ways to analyze data that will substantially advance the ability to understand the functional consequences of sequence variation and provide fundamental knowledge to directly or indirectly accelerate scientific and medical breakthroughs that improve human health.   

This FOA aims to develop approaches that can be used broadly to study the relationships among genetic variation, function, traits, and disease.  The focus should be on developing approaches that can be applied generally across multiple disease or trait outcomes.  Approaches may be tested using specific genomic elements, variants, cell types, diseases, traits, or model organisms; however, the generalizability of the approach must be explained well.  Approaches that are comprehensive across the genome and assay many or all variants at once are encouraged.  This PA is not intended for approaches that are only applicable to, or tailored towards, study of an individual disease, gene, or variant. 

Eligibility

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Award Budget
The combined budget for direct costs for the two-year project period may be up to $275,000 (exclusive of subcontract F&A). Up to $200,000 may be requested in any single year.

Award Project Period
The project period is 2 years.  

Scientific/Research Contact(s)
Lisa D. Brooks, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-547-1387 

Email: Lisa.Brooks@nih.gov

Financial/Grants Management Contact(s)
Lisa Oken
National Human Genome Research Institute (NHGRI)
Telephone: 301-594-5250 

Email:  loken@mail.nih.gov

Key Dates

Open Date (Earliest Submission Date): September 16, 2018.

Letter of Intent Due Date(s): Not Applicable

*Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review: Cycle III February - March

Advisory Council Review: Cycle III (May)

Earliest Start Date: Cycle III July 2019

Expiration Date: July 17, 2021

Deadline

Application Due Date(s): 

Cycle III (New): October 16, 2018 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Full details: https://grants.nih.gov/grants/guide/pa-files/PA-18-867.html

Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)

Activity Code
R01 Research Project Grant

Funding Opportunity Announcement (FOA) Number
PA-18-859

The purpose of this Funding Opportunity Announcement is to support research activities that will advance NIAID’s mission to develop a universal influenza vaccine providing durable protection against multiple influenza strains, including efforts to: 1) improve understanding of transmission, natural history and pathogenesis of influenza virus infection; 2) characterize influenza immunity and correlates of immune protection; and 3) support rational design of universal influenza vaccines. This FOA uses the R01 grant mechanism, while the companion FOA, PA-18-858, uses the R21 mechanism. Applicants with preliminary data and/or planning longer-term studies may wish to apply using the R01 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism.

Eligibility

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply

Award

Application budgets are not limited but need to reflect the actual needs of the proposed project.
The maximum project period is 5 years

Key Dates

Open Date (Earliest Submission Date)
September 05, 2018

More details at https://grants.nih.gov/grants/guide/pa-files/PA-18-859.html